Page last updated: 2024-08-26

mafosfamide and Neoplasms

mafosfamide has been researched along with Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahrami, SB; Beirne, E; Bertout, JA; Carleton, M; Casalini, JR; Chopra, R; Deckwerth, TL; Dey, J; Ditzler, SH; Filvaroff, EH; Frazier, JP; Girard, EJ; Grenley, MO; Hatton, BA; Kerwin, WS; Klinghoffer, RA; Meleo, KA; Moreno-Gonzalez, A; Morris, SM; Olson, JM; Pedro, KD; Press, OW; Strand, AD; Thirstrup, DJ; Tretyak, I; Veiseh, M; Watts, KL; You, S	1
Adamson, PC; Aikin, A; Arndt, CA; Balis, FM; Berg, S; Blaney, SM; Geyer, JR; Heideman, R; Jaeckle, K; Klenke, R; McCully, C; Murphy, R; Packer, R; Poplack, DG	1
Douay, L; Fechtenbaum, J; Gorin, NC; Lopez, M; Michon, J; Mortel, O; Palangie, T; Pouillart, P; Salmon, D; Zucker, JM	1
Myers, DE; Vallera, DA	1
Gambacorti-Passerini, C; Mariani, M; Parmiani, G; Radrizzani, M; Rivoltini, L; Supino, R	1

Reviews

2 review(s) available for mafosfamide and Neoplasms

Article	Year
Immunotoxins containing ricin. Cancer treatment and research, 1988, Volume: 37 Topics: Ammonium Chloride; Antibodies, Monoclonal; Cross-Linking Reagents; Cyclophosphamide; Drug Evaluation; Drug Synergism; Galactose; Humans; Immunotoxins; Leukemia; Melanoma; Neoplasms; Receptors, Mitogen; Ricin; Yttrium	1988
Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK). Cancer metastasis reviews, 1988, Volume: 7, Issue:4 Topics: Animals; Cell Survival; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Resistance; Humans; Immunity, Cellular; Immunotherapy; Interleukin-2; Killer Cells, Natural; Melanoma, Experimental; Neoplasms; Recombinant Proteins; Tumor Cells, Cultured	1988

Article

Year

Immunotoxins containing ricin.

Cancer treatment and research, 1988, Volume: 37

Topics: Ammonium Chloride; Antibodies, Monoclonal; Cross-Linking Reagents; Cyclophosphamide; Drug Evaluation; Drug Synergism; Galactose; Humans; Immunotoxins; Leukemia; Melanoma; Neoplasms; Receptors, Mitogen; Ricin; Yttrium

1988

Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK).

Cancer metastasis reviews, 1988, Volume: 7, Issue:4

Topics: Animals; Cell Survival; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Resistance; Humans; Immunity, Cellular; Immunotherapy; Interleukin-2; Killer Cells, Natural; Melanoma, Experimental; Neoplasms; Recombinant Proteins; Tumor Cells, Cultured

1988

Trials

2 trial(s) available for mafosfamide and Neoplasms

Article	Year
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Mar-01, Volume: 23, Issue:7 Topics: Animals; Antineoplastic Agents; Child, Preschool; Cyclophosphamide; Feasibility Studies; Humans; Injections, Spinal; Macaca mulatta; Meningeal Neoplasms; Meningitis; Neoplasms; Treatment Outcome	2005
Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells. Bone marrow transplantation, 1991, Volume: 7, Issue:3 Topics: Adolescent; Adult; Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Count; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Neoplasms; Transplantation, Autologous	1991

Article

Year

Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Mar-01, Volume: 23, Issue:7

Topics: Animals; Antineoplastic Agents; Child, Preschool; Cyclophosphamide; Feasibility Studies; Humans; Injections, Spinal; Macaca mulatta; Meningeal Neoplasms; Meningitis; Neoplasms; Treatment Outcome

2005

Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells.

Bone marrow transplantation, 1991, Volume: 7, Issue:3

Topics: Adolescent; Adult; Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Count; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Neoplasms; Transplantation, Autologous

1991

Other Studies

1 other study(ies) available for mafosfamide and Neoplasms

Article	Year
A technology platform to assess multiple cancer agents simultaneously within a patient's tumor. Science translational medicine, 2015, Apr-22, Volume: 7, Issue:284 Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cyclophosphamide; Dogs; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lymphoma; Mice; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Neoplasms; Prednisolone; TOR Serine-Threonine Kinases; Vincristine	2015

Article

Year

A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.

Science translational medicine, 2015, Apr-22, Volume: 7, Issue:284

Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cyclophosphamide; Dogs; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lymphoma; Mice; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Neoplasms; Prednisolone; TOR Serine-Threonine Kinases; Vincristine

2015